Killip classification mortality
Reading File
Searching PubMed
Killip classification acute myocardial infarction mortality
Finding Sources
Searching PubMed
Killip class mortality myocardial infarction
Reading File
Reading File
Here is the complete, textbook-verified breakdown of the Killip classification and its associated mortality:
Killip Classification (Killip & Kimball, 1967)
Originally proposed to risk-stratify patients with acute MI based on bedside clinical findings of heart failure severity.
| Class | Clinical Definition | Original In-Hospital Mortality |
|---|---|---|
| I | No signs or symptoms of heart failure | ~0-6% |
| II | Moderate HF: S3 gallop, basal pulmonary rales, tachypnea, JVD, or right-sided failure signs | ~10-20% |
| III | Severe HF: frank pulmonary edema (rales >50% of lung fields) | ~35-45% |
| IV | Cardiogenic shock: SBP <90 mmHg + peripheral vasoconstriction, cyanosis, mental confusion, oliguria | ~85-95% |
Key Points
Original data (1965-1967, n=250, no reperfusion therapy):
Per the Washington Manual table, mortality was: Class I = 6%, Class II = 17%, Class III = 38%, Class IV = 81%.
Modern era: Harrison's 22E notes that with advances in management (primary PCI, thrombolytics, ICU care), mortality in each class has fallen significantly - by roughly one-half compared to original figures.
Pathophysiology: Pump failure is now the primary cause of in-hospital death from STEMI. The degree of LV pump failure correlates directly with infarct size and drives the class assignment.
Clinical utility:
- Useful at the bedside for immediate risk stratification
- Class III/IV patients need urgent consideration of revascularization (primary PCI), hemodynamic support, and intensive monitoring
- High Killip class (III or IV) is an indication for early invasive strategy in guidelines
Recent interest: A 2024 review (Ponce-Gallegos et al., PMID 39411014) raises the question of whether the classification should be redefined in the ultrasound era, as point-of-care echo can detect subclinical congestion not captured by clinical exam alone. A 2023 study (Armillotta et al., PMID 37596114) validated the predictive value of Killip class in MINOCA (MI with non-obstructed coronary arteries) patients as well.
Sources: Washington Manual of Medical Therapeutics (Table 4-10, p.132); Harrison's Principles of Internal Medicine 22E, Chapter 286 - STEMI, Hemodynamic Assessment.
This is a shared conversation. Sign in to Orris to start your own chat.